Translocation and Downregulation of Protein Kinase C Isoenzymes-α and -ε by Phorbol Ester and Bryostatin-1 in Human Keratinocytes and Fibroblasts  by Reynolds, Nicholas J et al.
Translocation and Downregulation of Protein 
Kinase C Isoenzymes-a and -E by Phorbol Ester and 
Bryostatin-t in Human Keratinocytes and Fibroblasts 
Nicholas J. Reynolds, Joseph J. Baldassare, * Patricia A. Henderson, * John L. Shuler, Lawrence M. Ballas,:\: 
David J. Burns,:\: Cindy R. Moomaw,:\: and Gary J. Fished 
Departments of Dermatology, University of Michigan, Ann Arbor, Michigan;" Department of Internal Medicine, St. Louis University, 
St. Louis, Missouri; and :t:Sphinx Pharmaceuticals, Durham, North Carolina 
Protein kinase C isoenzymes can be subdivided into 
two classes, based on their requirement for calcium. 
Protein kinase Coo:, -PI, -PII, and -I' are calcium depen-
dent, whereas protein kinase Coy, "E, -C, -fl, and -f} are 
calcium independent. We have examined the expres-
sion, translocation, downregulation, and activation of 
calcium-dependent and -independent protein kinase C 
isoenzymes in human skin keratinocytes and fibro-
blasts. Human keratinocytes and fibroblasts expressed 
protein kinase CoO:, -t5, -E, and -C mRNA and protein, 
whereas protein kinase C-fl (L) was detected only in 
keratinocytes. Protein kinase C-PI, -PII, -J', and -f) were 
not detected in either cell type. The protein kinase C 
activators 12-0-tetradecanoylphorbol 13-acetate and 
Protein kinase C (PKC) is a multi gene family, encoded by at least nine genes, which plays a key role in signal trans-duction [1- 3]. On the basis of molecular structure and biochemical characteristics, PKC isoenzymes may be classified into conventional isoenzymes (PKC-a, -[JI, 
-[JII, and -y), which require Ca++ for activity, novel isoenzymes 
(PKC-o, -E, -C, -11 (L), and -8) , which are Ca++ independent, and 
atypical isoenzymes, (PKC-C and PKC-L[A]), which are Ca++ inde-
[
endent and are not activated by 1,2-diacylglycerol (1,2-DAG) 
1,2]. Conventional and novel PKC isoenzymes are activated by 
1,2-DAG, generated from membrane phospholipids in response to 
activation of cell surface receptors by a variety of extracellular medi-
ators [1,4] . The mechanism of atypical PKC activation is unknown. 
Conventional and novel PKC isoenzymes are the major cellular 
receptors for tumor-promoting phorbol esters, such as 12-0-tetra-
decanoylphorbol-13-acetate (TPA), which bind to and activate 
PKCs in a manner analogous to 1,2-DAG. PKC isoenzymes exhibit 
kinetic and substrate specificities in vitro and vary in their degree of 
activation by unsaturated fatty acids [1 ,5,6]. In addition, PKC isoen-
zymes display selective organ and cellular expression [2,7]. 
Depending on the cell type and its state of differentiation, PKC 
activation may either stimulate proliferation or reduce proliferation 
and stimulate differentiation. For example, TP A is mitogenic for 
murine fibroblast cell lines [8], whereas TPA stimulates differentia-
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bryostatin-1 (50 nM, for 5 min) induced translocation 
of protein kinase C-o: and -E cytosol to membrane in 
both keratinocytes and fibroblasts. 12-0-tetradecan-
oylphorbol 13-acetate and bryostatin-l, for 18 h, in-
duced complete downregulation (Le., loss) of protein 
kinase C-a and -E in keratinocytes, but only partial 
downregulation was observed in fibroblasts. The sub-
cellular distribution of protein kinase C-t5, -C or protein 
kinase C-", in keratinocytes or fibroblasts, did not 
change in response to 12-0-tetradecanoylphorbol 
13-acetate or bryostatin-1. These data indicate differ-
ential expression, subcellular distribution, and regula-
tion of protein kinase C isoenzymes in human skin 
cells.] Invest Dermato1103:364-369, 1994 
tion, with concomitant reduced cell growth, in human keratino-
cytes [9], HL-60 cells [10,11], and GH4 cells [12]. Studies in which 
specific PKC isoenzymes have been overexpressed in cells have 
provided evidence for the role of distinct isoenzymes in the control 
of growth and differentiation. For example, overexpression of 
PKC-[JI in murine or rat fibroblast cell lines [13], PKC-[JII antisense 
oligonucleotide in human erythroleukamic cell lines [14], and a 
dominant negative mutant of PKC-C in Swiss 3T3 cells [15], have 
demonstrated critical roles for PKC-[JI, PKC-[JII, and PKC-C in 
mitogenic signaling. On the other hand, in CHO cells, overexpres-
sion ofPKC-o resulted in arrest of cell division [16]. 
In vitro bryostatin-l binds to and activates PKC in a manner simi-
lar to TPA [8,17] . When added to cells, however, bryostatin-l does 
not always elicit responses similar to TP A. In cultured murine fi-
broblast cell lines, TP A and bryostatin-l are both strongly mito-
genic [8] , whereas in human keratinocytes TPA induces growth 
arrest and terminal differentiation, as assessed by increased choles-
terol sulfotransferase and type I transglutaminase activities and 
bryostatin- l does not affect keratinocyte growth or induce terminal 
differentiation [9,18] . Similarly, in HL-60 [10,11] and GH4 cells 
[12], TPA induces growth arrest and differentiation, whereas bry-
ostatin-l does not. In human dermal fibroblasts we have found that 
neither TPA or bryostatin-1, alone or in the presence of mitogenic 
growth factors (insulin and platelet-derived growth factor), affected 
DNA synthesis (unpublished observation). Furthermore, bryosta-
tin-1 inhibits many TPA-induced responses [8,10], including 
growth arrest and terminal differentiation of keratinocytes [9,19], 
and tumor promotion in mouse skin [20]. The mechanisms for the 
divergent effects of TPA and bryostatin-l are unknown; however, 
both qualitative and quantitative differences between TPA and 
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Table I. Protein Kinase C Isoenzyme Primer Sequences 
Primer Sequence (5' -> 3') Product Size (hp) 
PKC-a 5' 
PKC-a 3' 
PKC-flI 5' 
PKC-flI 3' 
PKC-flII5' 
PKC-flII3' 
PKC-y 5' 
PKC-y 3' 
PKC-c5 5' 
PKC-c5 3' 
PKC-E 5' 
PKC-E 3' 
PKC-'5' 
PKC-'3' 
PKC-r/5' 
PKC-I] 3' 
PKC-t1 5' 
PKC-83' 
GTCGGCAACAAAGTCATCAGTCCCTCTGAAGACAGGAAACAA 
TTTTAACGACTGAAACCCTACACGTTCCTT 
AAGGGCATCATTTACCGTGAC 
TGGAGGTTGAAGCTGTTTCTC 
AAGGGCATCATTTACCGTGAC 
524 
521 
641 
AATTTTGGGCTCAGTTCTCG 
GGTTCTACTCACCTCATACAATTCCAGGGGGTAGTT 
GTGTGTCGCGGCCACGTGCAAGTAGAGCGTCGTTCTTGT 
GTGGATTGCAAACAGTCTATGCGCAGTGAG 
TCTAGTCTGAGTCGGAGGAGTCTCGGA 
GACAATGAAGAGCGTGTGTTCAGGGAACGC 
TAACGACCACGGCTCAGGGGCGTCTGACGA 
CTAATGTTTGAGATGATGGCTGGG 
GTATCTGACCCTGAACGACCTCTT 
CCAGCTGAACCATCGCCAAATAGA 
ACACAGAGGTCTTAACGTTGG 
561 
525 
578 
267 
189 
AACCATGTCGCCATTTCT 
CACGTTTTTGCCTTTCAC 
bryostatin-1-induced PKC activation and patterns of substrate 
phosphorylations have been observed and provide possible explana-
tions [21-23]. 
PKC regulates epidermal growth, differentiation, and tumor 
promotion . Thus, skin provides a useful model system to study 
PKC-mediated signal transduction. Calcium-dependent and -inde-
pendent P~C activities .are ~etectable in ~1Um~n ski~ [24,25] and 
misregulauon of PKC s1gnal111g has been Imphcated 111 the patho-
genesis of the hyperproliferative skin disease psoriasis [26,27]. To 
better understand the role of PKC in skin, we have examined the 
expression of calcium-dependent and -independent PKC isoen-
zymes in normal human keratinocytes and fibroblasts at the mRNA 
and protein levels. In addition, we evaluated whether the divergent 
actions of TPA and bryostatin-1 on human keratinocytes and fi-
broblast growth and differentiation could be explained by differen-
tial effects on PKC isoenzyme translocation and activation. 
MATERIALS AND METHODS 
Materials TPA was from Sigma. Bryostatin-1 was a generous gift of Dr. 
G. R. Petitt. Monoclonal antibodies to PKC-a and -p (which recognizes 
PKC-PI and -flIl) were purchased from Seikagaku. Polyclonal isoenzyme-
specific antibodies to PKC-y, -15, -E, -C, and - I] were prepared in rabbits using 
synthetic peptides (28). Recombinant human PKC isoenzyme protein stan-
dards were prepared using the baculovirus/Sf9 insect cell expression system 
(28). 
Cell Culture Keratinocytes and dermal fibroblasts were cultured from 
keratome biopsies of adult human skin, as previously described [27 ,29). 
Reverse Transcriptase/Polymerase Chain Reaction Total RNA was 
prepared from c~ltured ~ells by. the isothiocyanate-~hloroform method 
using a commerCially avatlable kit (Stratagene) accordmg to the manufac-
rure's instructions. RNA was reversed transcribed, using random hexamer 
primers (2.5 J.LM) and 2.5 U/J.LI Moloney murine leukemia virus reverse 
transcriptase (Perkin Elmer Cetus) at 42 DC for 15 min. 5' and 3' PKC 
isoenzyme-specific primers (50 pmol each) were then added and polymerase 
chain reaction (PCR) amplification carried out for 32 cycles (95 DC for 30 
seconds, 55 DC for 30 seconds, and 72 D C for 30 seconds with 3 seconds 
extension per cycle). PCR products were electrophoresed in gels containing 
1.5% agarose (Gibco BRL) and 1.5% NuSieve (FMC), stained with ethi-
dium bromide, visualized with ultraviolet transillumination, and photo-
graphed. Sequences ofPCR primers utilized are given in Table I. To validate 
[heir authenticity, each PCR product was digested separately with two 
restriction enzymes, and digests were analyzed by agarose gel electropho-
resis. 
Western Blot Analysis Cells were placed in growth-factor - free MCDB 
153 for keratinocytes and serum-free Dulbecco's minimum essential me-
dium (DMEM) for fibroblasts, for 48 h. Cells were treated with agonists as 
specified in the text, washed 3 X with ice-cold Ca++ and Mg++-free phos-
phate-buffered saline, and scraped into a buffer (25 mM Tris-HCI, pH 7.5, 2 
241 
mM ethylenediaminetetraacetic ac id [EDTA), 2 mM ethyleneglycol-bis[P-
aminoethyl ether)-N, N, N', N' tetraacetic acid [EGTA), 0.5 mM dithio-
threitol, 0.02% Triton X-lOO, 10 mM EDTA, 1 mg/ml leupeptin, 25 
Ilg/ml aprotinin, 25 .ug/ ml antipain, 25 .ug/ ml pepstatin, 25.ug/ml chy-
mostatin, and 1 mM phcnylmethylsulphonyl fluoride). Samples were ho-
mogenized with 20 strokes in a Wheaton glass homogenizer and centri-
fuged at 100,000 X gat 4 DC for 1 h. Membrane fractions were dissolved in 
sodium dodecylsulfate (SDS) sample buffer. Supernatants were concentrated 
using Centricon 10 concentrators (Amicol1 Corp.) and mixed with an equal 
volume (approximately 75 J.LI) of2 X SDS sample buffer. Soluble and mem-
brane fractions and PKC isoenzyme standards were separated on 8% polyac-
rylamide gels (30), and proteins were transferred to nitrocellulose mem-
brane. Blots were blocked overnight in 20 mM Tris-HCI, pH 7.6,137 mM 
NaCI, 0.05% Tween 20, 2.5% powdered milk, and then incubated with 
anti-PKC antibodies diluted 1 : 200 (PKC-a and -/1) or 1 : 1000 (PKC-y, -0, 
-E, -" and -1]). Following washing, immunoreactive proteins were visualized 
using the enhanced chemiluminescence Western blotting detection system 
(Amersham). PKC band intensities were quantified by laser densitometry. 
Stimulation of PKC Isoenzymes by TPA and Bryostatin-l Enzy-
matic activity of partially purified recombinant human PKC isoenzymes was 
determined as described (31) in the presence of phosphatidylserine (2.ug/ 
ml), and either 1 ,2-diacylglycerol (2 .ug/ ml) or the indicated concentrations 
ofTPA or bryostatin-1, using myelin basic protein as substrate (250 .ug/ m1) . 
RESULTS 
PKC Isoenzyme Expression in Human Keratinocytes and 
Fibroblasts Using reverse transcriptase/PCR (see Table I for se-
quences ofpCR primers), we determined that keratinocytes express 
PKC-lX, -6, -E, -t;, and -I] , (L) mRNA (Fig lA) and fibroblasts 
express PKC-lX, -6, -E, and -t;, but not -17 transcripts (Fig IB). PKC-
fJI, -fJII, -y, and -8 transcripts were not found in keratinocytes or 
fibroblasts, although PKC-fJII transcripts were present in keratino-
cyte cultures containing residualmelanocytes (data not shown). As a 
positive control, PKC-fJI and -fJII were detectable in enriched prep-
arations of Langerhans cells, PKC-y was amplified from rat brain 
mRNA, and PKC-8 was amplified from human peripheral blood 
mononuclear cells (data not shown). Each PCR product yielded the 
expected size fragments following digestion with two restriction 
enzymes, thus confirming the authenticity of each product. 
We next examined PKC protein expression in soluble and mem-
brane cell fractions prepared from human keratinocytes and fibro-
blasts, by Western blot analysis, using isoenzyme-specific monoclo-
nal and polyclonal antibodies. PKC isoenzyme protein expression 
in keratinocytes (Fig 2) and fibroblasts (Fig 3) corresponded to the 
mRNAs expressed (Fig lA, B). PKC isoenzyme proteins were 
identified by their apparent n1.olecular weight on SDS gels and their 
co-migration with PKC isoenzyme protein standards (lane 1 in Figs 
2, 3). In untreated keratinocytes (Fig 2, lalle 2) and fibroblasts 
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Figure 1. PKe isoenzyme mRNA expression in cultured human 
keratinocytes (A) and dermal fibroblasts (B). mRNA was extracted 
from cultured cel1s, reversed transcribed, and PCR performed with isoen-
zyme-specific primers as described in Materials and Met/lOds. Lane 1, PKC-a; 
lane 2, PKC-!ll; lall e 3, PKC-,GlI; lalle4 , PKC-},; Jane 5, PKC-c5; Jalle 6, PKC-E; 
Jarle 7, PKC-(; lane 8, PKC-'1 (L). 
(Fig 3, lane 2), PKC-Q' (Figs 2A, 3A, lalle 2) and -( (Figs 2D, 3D, 
lal1e 2) were predominantly soluble (=95% and = 70%, respec-
tively), whereas PKC-J (Figs 2B, 3B, lane 2) was distributed ap-
proximately equally between soluble and membrane fractions. In 
keratinocytes and fibrobl asts, PKC-E (Fig 2C, lalle 2 and Fig 3C, 
lane 2, respectively) was predominantly soluble (70% - 90%), PKC-
1'/ in keratinocytes (Fig 2E, lane 2) was also predominantly soluble 
(> 95%). 
Translocation and Downregulation of PKe Isoenzymes in 
Response to Pborbol Ester and Bryostatin-l PKC isoenzyme 
activation is associated with translocation from the cytosol to the 
membrane, which occurs within minutes of agonist stimulation, 
and subsequent proteolytic degradation resulting in downregula-
tion, which typically occurs 3 - 18 h after addition of agonist. TP A 
and bryostatin-1 exert differential effects on keratinocyte and fi-
broblast growth and differentiation. W e (data not shown) and 
others [9,18] have demonstrated that TPA, but not bryostatin-1 , 
induces growth arrest and terminal differentiation in human kerati-
nocytes. In contras t, neither TP A nor bryostatin-l, either alone or 
in the presence of mitogenic growth factors, affected fibroblast 
growth (data not shown). We therefore examined the effects of 
TPA and bryostatin-1 on translocation and downregulatioll ofPKC 
isoenzymes in human keratinocytes and fibrobla sts . 
Short-term treatment of keratinocytes (Fig 2) and fibroblasts 
(Fig 3) with TPA (Fig 3, lane 3,50 nM for 5 min) and bryostatin-l 
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Figure 2. Translocation and downregulation ofPKC isoenzymes in 
human keratinocytes in response to TPA and bryostatin-1. Soluble (S) 
and membrane (M) cell fractions were prepared from keratinocytes treated 
with the specified agonists, separated by SOS-PAGE, and immunoblotted as 
described in Materials aud Methods. A, PKC-a; B, PKC-o; C, PKC-€; D, 
PKC-(; E, PKC-I/. Laue 1, PKC isoenzyme standard; la/Ie 2, control; IOlle 3, 
TPA (50 nM) for 5 min; lalle 4, TPA (50 11M) 18 h; lallc 5, bryostatin-1 (50 
nM) for 5 min; la/If 6, bryostatin-1 (50 nM) for 18 h. 
(Fig 3, lane 5, 50 nM for 5 min) induced partial translocation of 
PKC-Q' from the soluble fraction to the membrane. In response to 5 
min TPA or bryostatin-1 treatment, less than 10% of PKC-a trans-
located to the membrane in keratinocytes (Fig 2A, lane 3, and 
Table II), whereas in fibroblasts, TP A or bryostatin-l induced 
35% - 65% ofPKC-a to associate with the membrane (Fig 3A, lalle 
3, and Table III). In contrast, complete loss of PKC-E from the 
soluble fraction was observed in both keratinocytes (Fig 2C, Im'l es 3 
and 5, and Table II) and fibrobl asts (Fig 3C, lall es 3 alld 5, and Table 
III) , in response to TPA (50 nM) and bryostatin-1 (50 nM) for 5 
min. Densitometric analysis of W estern blots (data not shown) re-
vealed no significant reproducible changes in the patterns of distri-
bution ofPKC-o, -(, or -11 in keratinocytes (Fig 2B,D,E, lall es 3 alld 
5) or fibrobl as ts (Fig 3B,D, lall es 3 and 5) in response to TP A or 
bryostatin- l for 5 min or 15 min (data not shown). 
Long-term treatment with TPA or bryostatin-l (50 nM for 18 h) 
induced nearly complete downregulation ofPKC-a and -E in kera-
tinocytes (Fig 2A,C, lanes 4 and 6, and Table II), but only partial 
downregulation of PKC-a and -E was observed in fibroblasts (Fig 
3A,C, lanes 4 and 6, and Table III). N o consistent downregulatioll 
ofPKC-o, -(, or -1'/ was observed in response to long-term treatment 
with TPA or bryostatin-l in keratinocytes (Fig 2B,D,E, lanes 4 mid 
6, and data not shown) or fibroblasts (Fig 3B,D, larl es 4 alld 6, and 
data not shown). Borner et al [32] observed translocation ofPKC-O! 
to the membrane in rat fibroblasts following treatment with 300 
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Figure 3. Translocation and downregulation ofPKC isoenzymes in 
human dermal fibroblasts in response to TP A and bryostatin-1. Sol u-
ble (5) and membrane (M) ceLl fractions were prepared from fibrob lasts 
treated with the specified agonists, separated by SDS-PAGE, and immuno-
blotted as described in Materials and Methods, A, PKC-a; B, PKC-.5; C, 
PKC-€; D, PKC-(. La" e 1, PKC isoenzyme standard; lane 2, control; lane 3, 
TPA (50 nM) for 5 min; lane 4, TPA (50 nM) 18 h; laneS, bryostatin-l (50 
nM) for 5 min; lane 6, bryostatin-1 (50 nM) for 18 h. 
nM TP A but not 10 nM TPA. We therefore examined the effects of 
high-dose TPA and bryostatin-l treatment on the subcell ular distri-
bution of PKC isoenzymes in keratinocytes and fibroblasts. Similar 
changes in PKC isoenzyme translocation and downregulation were 
observed with 200 nM TPA or bryostatin-l, compared to 50 11M, in 
keratinocytes and fibrob lasts (data not shown). Thus, the absence of 
PKC-t5, -(, or -1'/ translocation or downregulation is unlikely to be 
due to low dosage of activators. 
Activation of Protein Kinase C-a, -15, -E, -C, and -rt In Vitro by 
TPA and Bryostatin-l Finall y, we examined the ability of 1,2-
DAG, TPA, and bryostatin-1 to activate itl llitro each of the PKC 
isoenzymes expressed in human keratinocytes and fibroblasts . En-
zymatic activities of recombinant human PKC-a, -15, -E, - (, and -1'/ 
were determined under standard assay conditions in the presence of 
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phosphatidylserine alone and with l,2-DAG, TPA, or bryostatin-l, 
using myelin basic protein as substrate. PKC-a, -15, -E, and -II were 
activated to similar extents by 1,2-DAG, TPA, and bryostatin-l 
(Fig 4) . Activation of PKC-a, -15, -E, and -1'/ by TP A and bryostatin-
1 was dose dependent between 1 and 50 nM. Interestingly, stimula-
tion of PKC-o and -E by low-dose (1 nM) TPA or bryostatin-l was 
significantly less than for PKC-a and -1'/. As expected , PKC-( was 
not significantly act ivated by either TPA or bryostatin-l compared 
to phosphatidylserine alone. 
DISCUSSION 
In this study we report expression of calcium-dependent and -inde-
pendent PKC isoenzymes in human keratinocytes and fibroblasts . 
The expression ofPKC-a, -0, -E, -(, and -1/ mRNA and protein, but 
not PKC-PI, -PII , or -1', in human keratinocytes is consistent with 
the reported mRNA expression in mouse keratinocytes [33]. In 
contrast, Gherzi etal [34] reported the presence ofPKC-a, -0, and -17 
but not PI, -PII, -y, -E, or -( mRNA, by Northern analysis in human 
keratinocytes cultured as a skin equival ent. Whether the cu lture 
conditions account for the difference is unknown. PKC-11 was orig-
inally cloned from a mouse epidermis eDNA library and was found 
to be most highly expressed in skin, lung, and heart [35,36]. PKC-II 
does not, however, appear to be expressed in dermal fibroblasts. 
Human dermal fibroblasts express PKC isoenzymes simil ar to rat 
embryo fibroblasts and Swiss 3T3 cells [32,37]. The presence of 
Ca++ -independent PKC isoenzymes in keratinocytes and fibro-
blasts provides signaling pathways through which agonists that in-
duce 1 ,2-DAG formation without increased intracellular Ca++ (i.e., 
through phosphatidylcholine hydrolysis) [38] may act. 
A significant proportion of PKC-E in fibroblasts was membrane 
associated, whereas in keratinocytcs PKC-E was nearly completely 
cytosolic. These findings suggest that the subcellular distribution of 
PKC isoenzymes is cell type dependent, rather than determined by 
the specific PKC isoenzy me per se, PKC-I'/ has been localized to the 
nuclear membrane fraction in A431 cells and immortalized kerati-
nocytes [39] . However, in our study PKC-17 was almost entirely in 
the cytosolic fraction. Furthermore, we have been unable to detect 
PKC-I'/ in nuclear fractions prepared from cultured human kerati-
nocytes (data not shown). Koizumi et al have recently reported 
localization of PKC-17 imJ1lunostaining in the cytoplasm in kerati-
nocytes in skin [40] . These data suggest that the subce llular distri-
bution of PKC-17 may differ between normal human keratinocytes 
and transformed keratinocyte cel l lines. 
Of the isoenzymes expressed in keratinocytes and fibroblasts, 
only PKC-o: and -E translocated to the membrane and underwent 
downregu lation in response to TPA and bryostatin-1. In addition, 
there were differences in responses to TP A and bryostatin-l be-
tween the two cell types studied. Translocation of PKC-a to the 
membrane in response to TP A and bryostatin-1 was more marked in 
fibroblasts compared to keratinocytes. Also, downregulation of 
membrane-associated PKC-a and -E was less com.plete in fibroblasts 
compared to keratinocytes. Selective translocation and downregu-
lation ofPKC isoenzymes in response to TPA have been reported in 
other cell types and may reflect differential susceptibility to proteol-
ysis or differences in subcellular localizatio n [41] . Our findings in-
dicate that although long-term treatment with TPA or bryostatin-1 
results in decreased Ca++-dependent PKC activity by 90% in 
Table II. TPA- and Bryostatin- l-Induced Translocation and Downregulation ofPKC-a and-E 
ill Cultured Human Keratinocytes" 
PKC 
Isoenzymc 
PKC-a 
PKC-E 
Control 
Soluble 
Fraction 
100 
100 
Membrane 
Fraction 
0.2 
7.9 
Relative PKC Lcvclsb (arbitrary units) 
TPA 5 Min TPA 18 H Bryostatin-I 5 Min 
Soluble Membrane Soluble Membrane Soluble Membrane 
Fraction Fraction Fraction Fraction Fraction Fraction 
96 5.0 12 0.3 140 3.8 
0.2 53 0.2 1.5 0.2 43 
Bryostatin-I 18 H 
Soluble 
Fraction 
2.9 
0.2 
Membrane 
Fraction 
0.2 
20 
• Va.lues were obtained by densitometry of W-cstcrn blots as shown in Fig 2. 3_nd arc represe ntative of three experime nts that yielded similar results . 
• Values are relative to soluble PKC-a or -E, which were set to a value of 100. 
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Table III. TP A- and Bryostatin-t- Induced Translocation and Downregulation of PKC-o: and -€ 
in Cultured Human Fibroblasts' 
Relative PKC Levelsb (arbitrary units) 
Control TPA 5 Min TPA 18 H Bryostatin-l 5 Min Bryostatin-l 18 H 
PKC Soluble Membrane Soluble Membrane Soluble Membrane Soluble Membrane Soluble Membrane 
Isoenzyme Fraction Fraction Fraction Fraction Fraction Fraction Fraction Fraction Fraction Fraction 
PKC-lX 100 6.1 40 70 17 36 78 38 0.2 11 
PKC-E 100 34 0.2 112 0.2 47 0.2 155 0.2 61 
• Values were obtained by densitometry of Western blots as shown in Fig l , and representative of three experiments that yielded simi lar results . 
• Values are relative to soluble PKC-C! or -E, which were set to a value of 100. 
human keratinocytes and fibrob lasts [42], Ca++-independent isoen-
zymes are still present. Thus, long-term pretreatment of keratino-
cytes or fibroblasts with TPA or bryostatin-l cannot be utilized to 
identify PKC-independent responses in these (and likely other) cell 
types, because levels of Ca++-independent PKCs remain relatively 
unchanged. 
TPA induces growth arrest and terminal differentiation in cul-
tured human keratinocytes, whereas bryostatin-1 does not [9,18]. In 
other cell types, divergent responses to TPA and bryostatin-l have 
been associated with selective translocation of PKC-PII to the nu-
cleus [21] or differences in the rate of downregulation of mem-
brane-associated PKC [22,23]. We, found no difference, however, 
between TP A and bryostatin-1 in induction of PKC isoenzyme 
translocation or downregulation in human keratinocytes . These 
data indicate that differential translocation and activation of PKC 
isoenzymes per se are not likely to account for differences in re-
sponses of keratinocytes to TP A and bryostatin-1. However, inhibi-
tion ofTPA-induced growth arrest and terminal differentiation by 
bryostatin-1, which downregulates PKC-a and -e, suggests that 
prolqnged activation of PKC-a or -e, may be required for these 
processes. In cultured human fibroblasts, TP A and bryostatin-1 do 
not significantly affect growth or differentiation, but do induce 
MARCKS protein phosphorylation [38] and also induce transloca-
tion of PKC-a and -E. MARCKS is a prominent cellular PKC sub-
strate, which may function to cross-link filamentous actin to the 
plasma membrane [43]. In fibroblasts, therefore, PKC may function 
to regulate cellular functions such as cytoskeletal organization and 
cell/matrix interactions [44,45] that were not addressed in this 
study. However, the demonstrated differential expression, sub cel-
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Figure 4. Dose dependent activation ofPKC isoenzymes in vitro by 
TPA and bryostatin-1. Partially purified, recombinant human PKC-lX 
(ALPHA), PKC-o (DELTA), PKC-E (EPSILON), PKC-( (ZETA), and 
PKC-'7 (ETA) were assayed for activity in the presence of phosphatidylserine 
plus 1 nM TPA (0), 50 nM TPA (mI), 1 nM bryostatin-l (_), or 50 nM 
bryostatin-l (G:I), as described in Materials and Methods. Data are displayed as 
percent of net 1 ,2-DAG -stimulated activity for PKC-lX, -0, - E, and -'1, or net 
phosphatidylserine-stimulated activity for PKC-C. The range of net 1,2-
DAG -stimulated specific activities (urnol/min/mg) for each isoenzyme 
was: PKC-lX, 45.8-47.4; PKC-o, 2.2-2.8; PKC-E, 10.0-11.0; PKC-C, 
1.0-1.4; PKC-'1, 4.0-4.5. Results are representative of three experiments 
performed in duplicate. 
lular distribution, and modulation by TP A and bryostatin-1 ofPKC 
isoenzymes in keratinocytes and fibroblasts is consistent with the 
concept that PKC isoenzyme may possess functional specificity in 
human keratinocytes and fibroblasts. 
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